17 January 2024 false No description of principal activity Taxfiler 2024.6 15420669business:PrivateLimitedCompanyLtd2024-01-172025-01-31 154206692024-01-16 154206692024-01-172025-01-31 15420669business:AuditExempt-NoAccountantsReport2024-01-172025-01-31 15420669business:FilletedAccounts2024-01-172025-01-31 154206692025-01-31 15420669business:Director12024-01-172025-01-31 15420669business:RegisteredOffice2024-01-172025-01-31 15420669core:WithinOneYear2025-01-31 15420669core:ShareCapitalcore:PreviouslyStatedAmount2025-01-31 15420669core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-01-31 15420669core:PreviouslyStatedAmount2025-01-31 15420669business:SmallEntities2024-01-172025-01-31 15420669countries:EnglandWales2024-01-172025-01-31 iso4217:GBP xbrli:pure
Company Registration No. 15420669 (England and Wales)
Aniqapharma Ltd Unaudited accounts for the period from 17 January 2024 to 31 January 2025
Aniqapharma Ltd Unaudited accounts Contents
Page
- 2 -
Aniqapharma Ltd Company Information for the period from 17 January 2024 to 31 January 2025
Director
Aniqa Anum Farooq
Company Number
15420669 (England and Wales)
Registered Office
Suite G04 1 Quality Court, Chancery Lane London WC2A 1HR England
- 3 -
Aniqapharma Ltd Statement of financial position as at 31 January 2025
2025 
Notes
£ 
Current assets
Debtors
1 
Cash at bank and in hand
14,183 
14,184 
Creditors: amounts falling due within one year
(4,343)
Net current assets
9,841 
Net assets
9,841 
Capital and reserves
Called up share capital
1 
Profit and loss account
9,840 
Shareholders' funds
9,841 
For the period ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 11 April 2025 and were signed on its behalf by
Aniqa Anum Farooq Director Company Registration No. 15420669
- 4 -
Aniqapharma Ltd Notes to the Accounts for the period from 17 January 2024 to 31 January 2025
1
Statutory information
Aniqapharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 15420669. The registered office is Suite G04 1 Quality Court, Chancery Lane, London, WC2A 1HR, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Debtors
2025 
£ 
Amounts falling due within one year
Other debtors
1 
5
Creditors: amounts falling due within one year
2025 
£ 
Taxes and social security
4,343 
6
Average number of employees
During the period the average number of employees was 0.
- 5 -